MYC/PGC-1α Balance Determines the Metabolic Phenotype and Plasticity of Pancreatic Cancer Stem Cells.

By P. Sancho, E. Burgos-Ramos, A. Tavera, Tony Bou Kheir, P. Jagušt, Matthieu Schoenhals, David Barneda, Katherine Sellers, R. Campos-Olivas, O. Graña and 4 more. Cell Metabolism, 2015

617 citations recorded by the source corpus.

Subfields: Molecular Biology, Oncology

View Paper: https://www.semanticscholar.org/paper/11df3d9c3d72212c741f580cfea79a346f25a4aa

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

1. D. Y. Gui
2. Alba Luengo
3. M. V. Vander Heiden
4. Ralph J. Deberardinis
5. Craig B. Thompson

In Oncology

1. M. V. Vander Heiden

Citations in the corpus

• Targeting Metabolism for Cancer Therapy (2017, background): “Consistent with this notion, other complex I inhibitors have shown efficacy as anti-tumor agents (Appleyard et al., 2012; Schockel et al., 2015) and may show selective toxicity against oncogene-ablation resistant cells (Viale et al., 2014) and cancer stem cells (Sancho et al., 2015).”